Literature DB >> 27993883

Association of Reduced Heme Oxygenase-1 with Decreased MicroRNA-196a2 Expression in Peripheral Blood Mononuclear Cells of Patients with Intestinal Behcet's Disease.

Jun Zou1, Da-Nian Ji2, Yan Shen1, Jian-Long Guan3,4, Song-Bai Zheng5,4.   

Abstract

AIMS: To examine the expression of miRNAs and mRNAs of heme oxygenase 1 (HO-1) in patients with active intestinal Behcet's disease (BD).
METHODS: Peripheral blood mononuclear cells (PBMCs) were obtained from BD patients with active ileocecal ulcers or from healthy donors. Expression levels of four miRNAs were studied using real-time PCR. The levels of mRNAs of ho-1, bach1, and CD14 were measured by qRT-PCR. Serum levels of cytokines were analyzed by ELISA.
RESULTS: Among four miRNAs, only levels of miR-196a2 were significantly decreased from BD patients with active ileocecal ulcers as compared with healthy controls. Moreover, level of mRNA ho-1 expression in PBMCs from patients with BD was reduced. No significant difference on bach1 and CD14 mRNA levels was observed. Levels of IFN-γ, IL-17, IL-10, IL-1β, and TNF-α were higher in patients with active intestinal BD than those in healthy controls.
CONCLUSION: The present results suggest that miR-196a2 expression is decreased in active intestinal BD patients. Down regulated miR-196a2 may be involved in intestinal BD pathogenesis by targeting Bach1/ho-1. Consequently, pro-inflammatory cytokines are closely implicated in the evolution of intestinal BD.
© 2016 by the Association of Clinical Scientists, Inc.

Entities:  

Keywords:  Bach1; Behcet’s disease (BD); heme oxygenase-1 (HO-1); ileocolonic ulcer; microRNA (miRNA)

Mesh:

Substances:

Year:  2016        PMID: 27993883

Source DB:  PubMed          Journal:  Ann Clin Lab Sci        ISSN: 0091-7370            Impact factor:   1.256


  1 in total

1.  Comprehensive miRNA Analysis Using Serum From Patients With Noninfectious Uveitis.

Authors:  Masaki Asakage; Yoshihiko Usui; Naoya Nezu; Hiroyuki Shimizu; Kinya Tsubota; Naoyuki Yamakawa; Masakatsu Takanashi; Masahiko Kuroda; Hiroshi Goto
Journal:  Invest Ophthalmol Vis Sci       Date:  2020-09-01       Impact factor: 4.799

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.